Drug Actives from Bench into Market.
Home About Girindus Capabilities Investor Relations Join us Events Contact us Sitemap
Deutsch
IR
Investor Relations
News
AdHoc Press
Press Releases
Director's Dealings
Pressclippings
Corporate Calendar
IR Contacts
Financial Reports
Shareholder Meeting
Archive
Factsheet
Stock Quote

Girindus  Sponsors  First  International  Oligonucleotide  Symposium

13.01.05 —

Bensberg, Germany, January 13, 2005: Girindus AG - listed in the Prime Segment of the German Stock Exchange - focused on process development and manufacturing of drug actives for the worldwide pharmaceutical and biotechnology industry announced that it will host its first International Oligonucleotide Technical Symposium on March 9, 2005 in Cincinnati, Ohio.

Girindus has assembled a distinguished group of leading industry and academic experts who will discuss recent advancements and future trends in oligonucleotide therapeutics. The symposium is coinciding with the inauguration of Girindus' new commercial scale oligonucleotide manufacturing facility. Following the conference the Cincinnati Chapter of the American Chemical Society will hold a dinner meeting.

The event is co-sponsored by the Genomics Research Institute and the Cincinnati Chapter of the American Chemical Society.

For more information please contact Inga Gwose in Europe [phone +49.2204.926.948 - igwose@girindus.com] or Rose Hawkins in the US [phone: +1.513.679.3072 - rhawkins@girindus.com].


top

                                                                                                                                                                                                                                                                                                                                                                                               

Scott Watson Joins Girindus as Vice President, Sales and Marketing
(01.08.08)

Girindus sells activities in Kuensebeck to Central Glass – Job security for the activities passed on
(02.06.08)

McLean joins Girindus Oligonucleotide Team
(14.05.08)

Girindus is planning separation from Halle-Künsebeck site and restructuring of administration departments
(09.01.08)

Girindus AG reicht GirLite Dossier bei EU Kommission ein
(04.01.08)

Girindus AG - Oligonucleotide Production Expansion Accelerated
(14.06.06)

Girindus AG – Solvay Beteiligung erreicht 75%
(13.06.06)

Girindus AG – Girindus informs the Governor of the State of Ohio, Bob Taft, about the latest developments
(19.10.05)

Girindus AG strengthens its Management Board by appointing Dr. Harald Mothes
(05.10.05)

Girindus AG - Erste Vertragsverhandlungen bestätigen Blockbusterpotential für GirLiteTM dA 100
(12.05.05)

Girindus AG – False Accusations Made By Animal Conservationists
(05.04.05)

Girindus AG – präsentiert den Jahresabschluss 2004 und stellt den Ausblick für die kommenden Jahre vor
(29.03.05)

Oligonucleotide Symposium – An Outstanding Success
(15.03.05)

Girindus Sponsors First International Oligonucleotide Symposium
(13.01.05)